{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:09:14Z","timestamp":1789042154415,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002366"],"award-info":[{"award-number":["UL1TR002366"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG052954"],"award-info":[{"award-number":["R01AG052954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01AG065487"],"award-info":[{"award-number":["K01AG065487"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG072973"],"award-info":[{"award-number":["P30AG072973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.plefa.2026.102762","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:19:28Z","timestamp":1784992768000},"page":"102762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Omega-3 fatty acids and Alzheimer\u2019s disease-related brain biomarkers in older adults enriched for preclinical Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-2028","authenticated-orcid":false,"given":"Danielle N","family":"Christifano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn A","family":"Honea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4368-2705","authenticated-orcid":false,"given":"Matthew K","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102762_bib0001","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.plefa.2026.102762_bib0002","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.plefa.2026.102762_bib0003","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"I. Alzheimer's Disease neuroimaging, association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMa"},{"key":"10.1016\/j.plefa.2026.102762_bib0004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.plefa.2026.102762_bib0005","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2026.102762_bib0006","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.neurobiolaging.2014.05.011","article-title":"APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years","volume":"35","author":"Taylor","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.plefa.2026.102762_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14336\/AD.2021.0529","article-title":"The cause of Alzheimer's Disease: the theory of multipathology convergence to chronic neuronal stress","volume":"13","author":"Decourt","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.plefa.2026.102762_bib0008","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/cells8020182","article-title":"Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation","volume":"8","author":"Farmer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.plefa.2026.102762_bib0009","article-title":"APOE4 Exerts partial diet-dependent effects on energy expenditure and skeletal muscle mitochondrial pathways in a preclinical model","volume":"6","author":"Johnson","year":"2025","journal-title":"Function. (Oxf)"},{"key":"10.1016\/j.plefa.2026.102762_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-016-0194-x","article-title":"The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease","volume":"8","author":"Yassine","year":"2016","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.plefa.2026.102762_bib0011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/026010600601800309","article-title":"Docosahexaenoic acid in neural signaling systems","volume":"18","author":"Crawford","year":"2006","journal-title":"Nutr. Health"},{"key":"10.1016\/j.plefa.2026.102762_bib0012","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3390\/molecules30153057","article-title":"Neuroprotective role of Omega-3 fatty acids: fighting Alzheimer's Disease","volume":"30","author":"Chavez-Castillo","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.plefa.2026.102762_bib0013","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.107.049619","article-title":"Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET","volume":"49","author":"Esposito","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.plefa.2026.102762_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2007.04.086","article-title":"Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults","volume":"421","author":"Conklin","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.plefa.2026.102762_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.0000000000000080","article-title":"Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study","volume":"82","author":"Pottala","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.plefa.2026.102762_bib0016","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e318249f6a9","article-title":"Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging","volume":"78","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.plefa.2026.102762_bib0017","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s11357-012-9453-3","article-title":"Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly","volume":"35","author":"Titova","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.plefa.2026.102762_bib0018","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.amepre.2014.05.037","article-title":"Regular fish consumption and age-related brain gray matter loss","volume":"47","author":"Raji","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.plefa.2026.102762_bib0019","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamaneurol.2016.1924","article-title":"Association of serum docosahexaenoic acid with cerebral amyloidosis","volume":"73","author":"Yassine","year":"2016","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.plefa.2026.102762_bib0020","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMa"},{"key":"10.1016\/j.plefa.2026.102762_bib0021","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-160439","article-title":"Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: a 12-month randomized, double-blind, placebo-controlled trial","volume":"55","author":"Zhang","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.plefa.2026.102762_bib0022","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1474-4422(17)30332-0","article-title":"g. LipiDiDiet clinical study, 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial","volume":"16","author":"Soininen","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.plefa.2026.102762_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/alz.12172","article-title":"g. LipiDiDiet clinical study, 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease","volume":"17","author":"Soininen","year":"2021","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.plefa.2026.102762_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102883","article-title":"Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial","volume":"59","author":"Arellanes","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.plefa.2026.102762_bib0025","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/cercor\/bht163","article-title":"Long-chain omega-3 fatty acids improve brain function and structure in older adults","volume":"24","author":"Witte","year":"2014","journal-title":"Cereb. Cortex."},{"key":"10.1016\/j.plefa.2026.102762_bib0026","doi-asserted-by":"crossref","first-page":"810","DOI":"10.14283\/jpad.2023.77","article-title":"Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia","volume":"10","author":"Yassine","year":"2023","journal-title":"J. Prev. Alzheimers. Dis."},{"key":"10.1016\/j.plefa.2026.102762_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106316","article-title":"CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial","volume":"129","author":"Yassine","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/j.plefa.2026.102762_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244893","article-title":"Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: a 1-year randomized controlled trial","volume":"16","author":"Vidoni","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.plefa.2026.102762_bib0029","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.plefa.2026.102762_bib0030","article-title":"Developing a Telephone Assessment of Physical Activity (TAPA) questionnaire for older adults","volume":"5","author":"Mayer","year":"2008","journal-title":"Prev. Chronic. Dis."},{"key":"10.1016\/j.plefa.2026.102762_bib0031","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1940-6207.CAPR-14-0351","article-title":"Omega-3 and omega-6 fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology","volume":"8","author":"Hidaka","year":"2015","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.plefa.2026.102762_bib0032","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jalz.2017.01.022","article-title":"Safety of disclosing amyloid status in cognitively normal older adults","volume":"13","author":"Burns","year":"2017","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.plefa.2026.102762_bib0033","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/RLU.0000000000001693","article-title":"Augmenting amyloid PET interpretations with quantitative information improves consistency of early amyloid detection","volume":"42","author":"Harn","year":"2017","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.plefa.2026.102762_bib0034","doi-asserted-by":"crossref","first-page":"18661","DOI":"10.1074\/jbc.R700015200","article-title":"Novel metabolism of docosahexaenoic acid in neural cells","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102762_bib0035","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","article-title":"Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms","volume":"286","author":"Grimm","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102762_bib0036","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2026.102762_bib0037","doi-asserted-by":"crossref","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3593-07.2007","article-title":"Omega-3 fatty acid docosahexaenoic acid increases SorLA\/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention","volume":"27","author":"Ma","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.plefa.2026.102762_bib0038","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-130131","article-title":"Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers","volume":"35","author":"Hjorth","year":"2013","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.plefa.2026.102762_bib0039","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jcmm.16098","article-title":"Maresin 1 attenuates pro-inflammatory activation induced by beta-amyloid and stimulates its uptake","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.plefa.2026.102762_bib0040","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.plefa.2026.102762_bib0041","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1074\/jbc.M115.698001","article-title":"Different fatty acids compete with arachidonic acid for binding to the allosteric or catalytic subunits of cyclooxygenases to regulate prostanoid synthesis","volume":"291","author":"Dong","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2026.102762_bib0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2026.102762_bib0043","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbi.2015.12.013","article-title":"Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro","volume":"55","author":"Rey","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"Suppl 1","key":"10.1016\/j.plefa.2026.102762_bib0044","first-page":"S200","article-title":"Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus","volume":"153","author":"Serhan","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102762_bib0045","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1017\/S000711451200147X","article-title":"Dietary methods and biomarkers of omega 3 fatty acids: a systematic review","volume":"107","author":"Serra-Majem","year":"2012","journal-title":"Br. J. Nutr."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:19:29Z","timestamp":1789039169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327826000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0952327826000402"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102762","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids and Alzheimer\u2019s disease-related brain biomarkers in older adults enriched for preclinical Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102762"}}